Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Invitae Corporation    NVTA

INVITAE CORPORATION

(NVTA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/21/2020 09/22/2020 09/23/2020 09/24/2020 09/25/2020 Date
40.59(c) 43.1(c) 40.75(c) 42.71(c) 44.67(c) Last
4 300 803 3 465 506 3 302 148 2 849 109 2 550 546 Volume
+1.48% +6.18% -5.45% +4.81% +4.59% Change
More quotes
Financials (USD)
Sales 2020 257 M - -
Net income 2020 -417 M - -
Net Debt 2020 19,7 M - -
P/E ratio 2020 -13,8x
Yield 2020 -
Sales 2021 490 M - -
Net income 2021 -252 M - -
Net Debt 2021 107 M - -
P/E ratio 2021 -29,0x
Yield 2021 -
Capitalization 5 887 M 5 887 M -
EV / Sales 2020 23,0x
EV / Sales 2021 12,2x
Nbr of Employees 1 500
Free-Float 99,1%
More Financials
Company
Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for... 
More about the company
Notations Surperformance© of Invitae Corporation
Trading Rating : Investor Rating :
More Ratings
All news about INVITAE CORPORATION
09/11INVITAE CORP : Change in Directors or Principal Officers (form 8-K)
AQ
09/11INVITAE : Appoints Kimber Lockhart to its Board of Directors
PR
09/10PTC THERAPEUTICS : Launches PTC PINPOINT A Genetic Testing Program for Individua..
AQ
09/09INVITAE : PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for..
PR
09/01INVITAE : to Participate in the Morgan Stanley Virtual Global Healthcare Confere..
PR
08/04INVITAE : Reports Inducement Grants Under NYSE Rule 303A.08
PR
08/04INVITAE : 2Q Earnings Snapshot
AQ
08/04INVITAE : Management's Discussion and Analysis of Financial Condition and Result..
AQ
08/04INVITAE CORP : Results of Operations and Financial Condition (form 8-K)
AQ
08/04INVITAE : Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples A..
PR
07/21INVITAE : to Announce Second Quarter 2020 Financial Results on August 4, 2020
PR
07/08INVITAE : Moore Kuehn Encourages DCOM, MYOS, ADSW, and NVTA Investors to Contact..
PR
07/01INVITAE INVESTOR ALERT BY THE FORMER : Kahn Swick & Foti, LLC Investigates Merge..
BU
06/26INVITAE MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whe..
PR
06/26INVITAE CORP : Change in Directors or Principal Officers, Financial Statements a..
AQ
More news
News in other languages on INVITAE CORPORATION
08/14Deutsche Bank sieht Qiagen-Kurs nach gefloppter Übernahme durchstarten
06/24DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 24.06.2020 - 15.15 Uhr
06/24Qiagen winkt hoher Sondergewinn aus Verkauf einer US-Beteiligung
06/24Aktien Frankfurt Ausblick: Moderate Verluste erwartet
06/23KORREKTUR : Qiagen winkt hoher Sondergewinn durch Verkauf von US-Beteiligung
More news
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 36,25 $
Last Close Price 44,67 $
Spread / Highest target -14,9%
Spread / Average Target -18,8%
Spread / Lowest Target -23,9%
EPS Revisions
Managers
NameTitle
Sean Emerson George Chairman, President & Chief Executive Officer
Kenneth D. Knight Chief Operating Officer
Shelly D. Guyer Chief Financial Officer
Robert Nussbaum Chief Medical Officer
Eric I. Aguiar Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
INVITAE CORPORATION176.94%5 887
EXACT SCIENCES CORPORATION5.64%14 671
GUARDANT HEALTH, INC.43.08%11 116
BGI GENOMICS CO., LTD.112.56%8 477
ADAPTIVE BIOTECHNOLOGIES CORPORATION61.40%6 557
SEEGENE INC--.--%5 391